Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Urinary Bladder Neoplasms × Lapatinib × Clear all

Phase

Status

Terminated 3 Completed 2 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 11 Neoplasm Metastasis 2 HER2 Positive Metastatic Breast Cancer 2 Urinary Bladder Neoplasms 1 Oesophagogastric Cancer 1 Neoplasms 1 Invasive Breast Cancer 1 HER2-positive Advanced Breast Cancer 1 Gastrointestinal Neoplasms 1 Gallbladder Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Diseases 1

Interventions

Gemcitabine 7 Cystectomy 5 Cisplatin 5 durvalumab 4 Neoadjuvant Therapy 4 Mitomycin 4 Transurethral Resection of Bladder 3 Nivolumab 3 Epirubicin 3 Chemoradiotherapy 3 BCG Vaccine 3 Anesthesia, Spinal 3 tislelizumab 2 catumaxomab 2 atezolizumab 2 Vitamin E 2 Urinary Diversion 2 Sunitinib 2 Selenium 2 Robotic Surgical Procedures 2 Multiparametric Magnetic Resonance Imaging 2 Magnetic Resonance Imaging 2 Immunohistochemistry 2 Fentanyl 2 Diathermy 2 Cystoscopy 2 Chemoprevention 2 BCG Connaught 2 Anesthesia, General 2 valrubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00949455 2015-04-15

LaMB

Queen Mary University of London

Phase 2/3 Unknown

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡